4.0
Dec 31, 2025
Recommend
CEO approval
Business Outlook
Pros
Robust pipeline - tons of opportunities for growth/development Improved transparency around promotions process
Cons
Pay could be better Innovation is lagging behind peers in some therapeutic areas